APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Injectable Suspension Budesonide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Injectable Suspension Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003220319 December 2025194 pages

Choose your research edition.

Industry ResearchInjectable Suspension Budesonide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Suspension Budesonide Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Injectable Suspension Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Suspension Budesonide Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Suspension Budesonide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Injectable Suspension Budesonide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Suspension Budesonide include Teva, Shanghai Sine Promod, Sandoz, Mylan, Lunan Better Pharma, Synmosa Biopharma, AstraZeneca, Salix and Orion Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Suspension Budesonide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Suspension Budesonide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Suspension Budesonide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Suspension Budesonide market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Suspension Budesonide Segment by Company

Teva

Shanghai Sine Promod

Sandoz

Mylan

Lunan Better Pharma

Synmosa Biopharma

AstraZeneca

Salix

Orion Corporation

Cosmo Pharmaceuticals

Cipla

Chiesi Farmaceutici

Injectable Suspension Budesonide Segment by Type

0.5mg

1mg

Injectable Suspension Budesonide Segment by Application

Inflammatory Bowel Disease Treatment

Respiratory Disease Treatment

Nose Disease Treatment

Other

Injectable Suspension Budesonide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Suspension Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Suspension Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Suspension Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Suspension Budesonide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Suspension Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Injectable Suspension Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Injectable Suspension Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Injectable Suspension Budesonide Industry Trends Table 2. Injectable Suspension Budesonide Industry Drivers Table 3. Injectable Suspension Budesonide Industry Opportunities and Challenges Table 4. Injectable Suspension Budesonide Industry Restraints Table 5. Global Injectable Suspension Budesonide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Injectable Suspension Budesonide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Injectable Suspension Budesonide Sales by Manufacturers (K L) & (2021-2026) Table 8. Global Injectable Suspension Budesonide Sales Market Share by Manufacturers Table 9. Global Injectable Suspension Budesonide Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global Injectable Suspension Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Injectable Suspension Budesonide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Injectable Suspension Budesonide Manufacturers, Product Type & Application Table 13. Global Injectable Suspension Budesonide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Suspension Budesonide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.5mg Table 17. Major Manufacturers of 1mg Table 18. Global Injectable Suspension Budesonide Sales by Type 2021 VS 2025 VS 2032 (K L) Table 19. Global Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 20. Global Injectable Suspension Budesonide Sales by Type (2027-2032) & (K L) Table 21. Global Injectable Suspension Budesonide Sales Market Share by Type (2021-2026) Table 22. Global Injectable Suspension Budesonide Sales Market Share by Type (2027-2032) Table 23. Global Injectable Suspension Budesonide Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 24. Global Injectable Suspension Budesonide Revenue by Type (2021-2026) & (K L) Table 25. Global Injectable Suspension Budesonide Revenue by Type (2027-2032) & (K L) Table 26. Global Injectable Suspension Budesonide Revenue Market Share by Type (2021-2026) Table 27. Global Injectable Suspension Budesonide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Inflammatory Bowel Disease Treatment Table 29. Major Manufacturers of Respiratory Disease Treatment Table 30. Major Manufacturers of Nose Disease Treatment Table 31. Major Manufacturers of Other Table 32. Global Injectable Suspension Budesonide Sales by Application 2021 VS 2025 VS 2032 (K L) Table 33. Global Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 34. Global Injectable Suspension Budesonide Sales by Application (2027-2032) & (K L) Table 35. Global Injectable Suspension Budesonide Sales Market Share by Application (2021-2026) Table 36. Global Injectable Suspension Budesonide Sales Market Share by Application (2027-2032) Table 37. Global Injectable Suspension Budesonide Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 38. Global Injectable Suspension Budesonide Revenue by Application (2021-2026) & (K L) Table 39. Global Injectable Suspension Budesonide Revenue by Application (2027-2032) & (K L) Table 40. Global Injectable Suspension Budesonide Revenue Market Share by Application (2021-2026) Table 41. Global Injectable Suspension Budesonide Revenue Market Share by Application (2027-2032) Table 42. Global Injectable Suspension Budesonide Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 43. Global Injectable Suspension Budesonide Sales by Region (2021-2026) & (K L) Table 44. Global Injectable Suspension Budesonide Sales Market Share by Region (2021-2026) Table 45. Global Injectable Suspension Budesonide Sales Forecasted by Region (2027-2032) & (K L) Table 46. Global Injectable Suspension Budesonide Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 48. North America Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 49. North America Injectable Suspension Budesonide Sales by Country (2027-2032) & (K L) Table 50. Europe Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 51. Europe Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 52. Europe Injectable Suspension Budesonide Sales by Country (2027-2032) & (K L) Table 53. Asia Pacific Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 54. Asia Pacific Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 55. Asia Pacific Injectable Suspension Budesonide Sales by Country (2027-2032) & (K L) Table 56. South America, Middle East and Africa Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 57. South America, Middle East and Africa Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 58. South America, Middle East and Africa Injectable Suspension Budesonide Sales by Country (2027-2032) & (K L) Table 59. Global Injectable Suspension Budesonide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Injectable Suspension Budesonide Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Injectable Suspension Budesonide Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Injectable Suspension Budesonide Revenue Market Share by Region (2021-2026) Table 63. Global Injectable Suspension Budesonide Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Injectable Suspension Budesonide Product Portfolio Table 68. Teva Recent Development Table 69. Shanghai Sine Promod Company Information Table 70. Shanghai Sine Promod Business Overview Table 71. Shanghai Sine Promod Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shanghai Sine Promod Injectable Suspension Budesonide Product Portfolio Table 73. Shanghai Sine Promod Recent Development Table 74. Sandoz Company Information Table 75. Sandoz Business Overview Table 76. Sandoz Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sandoz Injectable Suspension Budesonide Product Portfolio Table 78. Sandoz Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Injectable Suspension Budesonide Product Portfolio Table 83. Mylan Recent Development Table 84. Lunan Better Pharma Company Information Table 85. Lunan Better Pharma Business Overview Table 86. Lunan Better Pharma Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lunan Better Pharma Injectable Suspension Budesonide Product Portfolio Table 88. Lunan Better Pharma Recent Development Table 89. Synmosa Biopharma Company Information Table 90. Synmosa Biopharma Business Overview Table 91. Synmosa Biopharma Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Synmosa Biopharma Injectable Suspension Budesonide Product Portfolio Table 93. Synmosa Biopharma Recent Development Table 94. AstraZeneca Company Information Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. AstraZeneca Injectable Suspension Budesonide Product Portfolio Table 98. AstraZeneca Recent Development Table 99. Salix Company Information Table 100. Salix Business Overview Table 101. Salix Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Salix Injectable Suspension Budesonide Product Portfolio Table 103. Salix Recent Development Table 104. Orion Corporation Company Information Table 105. Orion Corporation Business Overview Table 106. Orion Corporation Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Orion Corporation Injectable Suspension Budesonide Product Portfolio Table 108. Orion Corporation Recent Development Table 109. Cosmo Pharmaceuticals Company Information Table 110. Cosmo Pharmaceuticals Business Overview Table 111. Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Portfolio Table 113. Cosmo Pharmaceuticals Recent Development Table 114. Cipla Company Information Table 115. Cipla Business Overview Table 116. Cipla Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Cipla Injectable Suspension Budesonide Product Portfolio Table 118. Cipla Recent Development Table 119. Chiesi Farmaceutici Company Information Table 120. Chiesi Farmaceutici Business Overview Table 121. Chiesi Farmaceutici Injectable Suspension Budesonide Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Chiesi Farmaceutici Injectable Suspension Budesonide Product Portfolio Table 123. Chiesi Farmaceutici Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Injectable Suspension Budesonide Distributors List Table 127. Injectable Suspension Budesonide Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Injectable Suspension Budesonide Product Image Figure 2. Global Injectable Suspension Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Suspension Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Suspension Budesonide Sales (2021-2032) & (K L) Figure 5. Global Injectable Suspension Budesonide Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 Injectable Suspension Budesonide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.5mg Image Figure 9. 1mg Image Figure 10. Global Injectable Suspension Budesonide Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 11. Global Injectable Suspension Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Injectable Suspension Budesonide Sales Market Share by Type (2021-2032) Figure 13. Global Injectable Suspension Budesonide Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Injectable Suspension Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Injectable Suspension Budesonide Revenue Market Share by Type (2021-2032) Figure 16. Inflammatory Bowel Disease Treatment Image Figure 17. Respiratory Disease Treatment Image Figure 18. Nose Disease Treatment Image Figure 19. Other Image Figure 20. Global Injectable Suspension Budesonide Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 21. Global Injectable Suspension Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Injectable Suspension Budesonide Sales Market Share by Application (2021-2032) Figure 23. Global Injectable Suspension Budesonide Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 24. Global Injectable Suspension Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Injectable Suspension Budesonide Revenue Market Share by Application (2021-2032) Figure 26. North America Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 27. North America Injectable Suspension Budesonide Sales Market Share by Country (2021-2032) Figure 28. U.S. Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 29. Canada Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 30. Mexico Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 31. Europe Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 32. Europe Injectable Suspension Budesonide Sales Market Share by Country (2021-2032) Figure 33. Germany Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 34. France Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 35. U.K. Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 36. Italy Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 37. Netherlands Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 38. Asia Pacific Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 39. Asia Pacific Injectable Suspension Budesonide Sales Market Share by Country (2021-2032) Figure 40. China Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 41. Japan Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 42. South Korea Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 43. Southeast Asia Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 44. India Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 45. Australia Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 46. South America, Middle East and Africa Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 47. South America, Middle East and Africa Injectable Suspension Budesonide Sales Market Share by Country (2021-2032) Figure 48. Brazil Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 49. South Africa Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 50. Saudi Arabia Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 51. Turkey Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 52. Argentina Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 53. UAE Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 54. Egypt Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 55. Chile Injectable Suspension Budesonide Sales and Growth Rate (2021-2032) & (K L) Figure 56. Global Injectable Suspension Budesonide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Injectable Suspension Budesonide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Injectable Suspension Budesonide Revenue (2021-2032) & (US$ Million) Figure 59. North America Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Injectable Suspension Budesonide Revenue (2021-2032) & (US$ Million) Figure 61. Europe Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Injectable Suspension Budesonide Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Injectable Suspension Budesonide Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Injectable Suspension Budesonide Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Injectable Suspension Budesonide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg
  • 1mg
Applications
  • Inflammatory Bowel Disease Treatment
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Other
Companies covered
  • Teva
  • Shanghai Sine Promod
  • Sandoz
  • Mylan
  • Lunan Better Pharma
  • Synmosa Biopharma
  • AstraZeneca
  • Salix
  • Orion Corporation
  • Cosmo Pharmaceuticals
  • Cipla
  • Chiesi Farmaceutici

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Injectable Suspension Budesonide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Injectable Suspension Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Injectable Suspension Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Injectable Suspension Budesonide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Injectable Suspension Budesonide Market Dynamics
  1. 2.1 Injectable Suspension Budesonide Industry Trends
  2. 2.2 Injectable Suspension Budesonide Industry Drivers
  3. 2.3 Injectable Suspension Budesonide Industry Opportunities and Challenges
  4. 2.4 Injectable Suspension Budesonide Industry Restraints
3 Injectable Suspension Budesonide Market by Manufacturers
  1. 3.1 Global Injectable Suspension Budesonide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Injectable Suspension Budesonide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Injectable Suspension Budesonide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Injectable Suspension Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Suspension Budesonide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Injectable Suspension Budesonide Manufacturers, Product Type & Application
  7. 3.7 Global Injectable Suspension Budesonide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Suspension Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Suspension Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Suspension Budesonide Tier 1, Tier 2, and Tier 3
4 Injectable Suspension Budesonide Market by Type
  1. 4.1 Injectable Suspension Budesonide Type Introduction
  2. 4.1.1 0.5mg
  3. 4.1.2 1mg
  4. 4.2 Global Injectable Suspension Budesonide Sales by Type
  5. 4.2.1 Global Injectable Suspension Budesonide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Injectable Suspension Budesonide Sales by Type (2021-2032)
  7. 4.2.3 Global Injectable Suspension Budesonide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Injectable Suspension Budesonide Revenue by Type
  9. 4.3.1 Global Injectable Suspension Budesonide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Injectable Suspension Budesonide Revenue by Type (2021-2032)
  11. 4.3.3 Global Injectable Suspension Budesonide Revenue Market Share by Type (2021-2032)
5 Injectable Suspension Budesonide Market by Application
  1. 5.1 Injectable Suspension Budesonide Application Introduction
  2. 5.1.1 Inflammatory Bowel Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Nose Disease Treatment
  5. 5.1.4 Other
  6. 5.2 Global Injectable Suspension Budesonide Sales by Application
  7. 5.2.1 Global Injectable Suspension Budesonide Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Injectable Suspension Budesonide Sales by Application (2021-2032)
  9. 5.2.3 Global Injectable Suspension Budesonide Sales Market Share by Application (2021-2032)
  10. 5.3 Global Injectable Suspension Budesonide Revenue by Application
  11. 5.3.1 Global Injectable Suspension Budesonide Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Injectable Suspension Budesonide Revenue by Application (2021-2032)
  13. 5.3.3 Global Injectable Suspension Budesonide Revenue Market Share by Application (2021-2032)
6 Global Injectable Suspension Budesonide Sales by Region
  1. 6.1 Global Injectable Suspension Budesonide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Suspension Budesonide Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Suspension Budesonide Sales by Region (2021-2026)
  4. 6.2.2 Global Injectable Suspension Budesonide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Injectable Suspension Budesonide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Injectable Suspension Budesonide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Injectable Suspension Budesonide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Injectable Suspension Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Injectable Suspension Budesonide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Injectable Suspension Budesonide Revenue by Region
  1. 7.1 Global Injectable Suspension Budesonide Revenue by Region
  2. 7.1.1 Global Injectable Suspension Budesonide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Injectable Suspension Budesonide Revenue by Region (2021-2026)
  4. 7.1.3 Global Injectable Suspension Budesonide Revenue by Region (2027-2032)
  5. 7.1.4 Global Injectable Suspension Budesonide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Injectable Suspension Budesonide Revenue (2021-2032)
  8. 7.2.2 North America Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Injectable Suspension Budesonide Revenue (2021-2032)
  11. 7.3.2 Europe Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Injectable Suspension Budesonide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Injectable Suspension Budesonide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Injectable Suspension Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Injectable Suspension Budesonide Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Shanghai Sine Promod
  8. 8.2.1 Shanghai Sine Promod Company Information
  9. 8.2.2 Shanghai Sine Promod Business Overview
  10. 8.2.3 Shanghai Sine Promod Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Sine Promod Injectable Suspension Budesonide Product Portfolio
  12. 8.2.5 Shanghai Sine Promod Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Injectable Suspension Budesonide Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Injectable Suspension Budesonide Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Lunan Better Pharma
  26. 8.5.1 Lunan Better Pharma Company Information
  27. 8.5.2 Lunan Better Pharma Business Overview
  28. 8.5.3 Lunan Better Pharma Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lunan Better Pharma Injectable Suspension Budesonide Product Portfolio
  30. 8.5.5 Lunan Better Pharma Recent Developments
  31. 8.6 Synmosa Biopharma
  32. 8.6.1 Synmosa Biopharma Company Information
  33. 8.6.2 Synmosa Biopharma Business Overview
  34. 8.6.3 Synmosa Biopharma Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Synmosa Biopharma Injectable Suspension Budesonide Product Portfolio
  36. 8.6.5 Synmosa Biopharma Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Injectable Suspension Budesonide Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Salix
  44. 8.8.1 Salix Company Information
  45. 8.8.2 Salix Business Overview
  46. 8.8.3 Salix Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Salix Injectable Suspension Budesonide Product Portfolio
  48. 8.8.5 Salix Recent Developments
  49. 8.9 Orion Corporation
  50. 8.9.1 Orion Corporation Company Information
  51. 8.9.2 Orion Corporation Business Overview
  52. 8.9.3 Orion Corporation Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orion Corporation Injectable Suspension Budesonide Product Portfolio
  54. 8.9.5 Orion Corporation Recent Developments
  55. 8.10 Cosmo Pharmaceuticals
  56. 8.10.1 Cosmo Pharmaceuticals Company Information
  57. 8.10.2 Cosmo Pharmaceuticals Business Overview
  58. 8.10.3 Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Portfolio
  60. 8.10.5 Cosmo Pharmaceuticals Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Injectable Suspension Budesonide Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Chiesi Farmaceutici
  68. 8.12.1 Chiesi Farmaceutici Company Information
  69. 8.12.2 Chiesi Farmaceutici Business Overview
  70. 8.12.3 Chiesi Farmaceutici Injectable Suspension Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chiesi Farmaceutici Injectable Suspension Budesonide Product Portfolio
  72. 8.12.5 Chiesi Farmaceutici Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Suspension Budesonide Value Chain Analysis
  2. 9.1.1 Injectable Suspension Budesonide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Suspension Budesonide Production Mode & Process
  6. 9.2 Injectable Suspension Budesonide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Suspension Budesonide Distributors
  9. 9.2.3 Injectable Suspension Budesonide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst